Market Overview

Global Endovascular Treatment Devices 2018-2022 - Major Players Profiled Include Boston Scientific Corp., Cardinal Health, Cook Group Inc., Getinge AB and Terumo Corp

Share:

Global Endovascular Treatment Devices 2018-2022 - Major Players Profiled Include Boston Scientific Corp., Cardinal Health, Cook Group Inc., Getinge AB and Terumo Corp

PR Newswire

DUBLIN, Aug. 22, 2018 /PRNewswire/ --

Research and Markets Logo. (PRNewsFoto/Research and Markets) (PRNewsfoto/Research and Markets)

The "Endovascular Treatment Devices: EVAR and TEVAR Emphasis" report has been added to ResearchAndMarkets.com's offering.

Endovascular treatment includes procedure types such as EVAR and TEVAR. Aneurysm types include infrarenal, juxtarenal and thoracic. This report is an analytical business tool with the primary purpose of providing a thorough evaluation of the global market for endovascular treatment for aneurysms.

The format of this study includes the following:

  • Detailed description, including demographics and cost burden, of aortic diseases (abdominal aortic aneurysms and thoracic aortic aneurysms) and aneurysm types (e.g., infrarenal, juxtarenal and thoracic).
  • Detailed description and analysis of endovascular treatment devices including EVAR and TEVAR.
  • Market characterization, including unmet need, market size, and segmentation (by region and treatment).
  • Market drivers and restraints.
  • Detailed market projections through 2022.
  • Competition and market shares.
  • Key marketed and pipeline (R&D) products along with information about their regulatory status.
  • Strategic landscape (mergers and acquisitions).
  • Regulatory structure.
  • Pricing and reimbursement.
  • Observations and conclusions regarding the future of endovascular treatment.
  • Profiles of market participants and associations.

The Report Includes:

  • 20 data tables and 14 additional tables
  • A global overview of the endovascular treatment market with an emphasis on Endovascular Aortic Repair (EVAR) and Thoracic Endovascular Aortic/aneurysm Repair (TEVAR)
  • Analyses of global market trends with data from 2016 and 2017, and projections of compound annual growth rates (CAGRs) through 2022
  • Coverage of the endovascular treatment market's regulatory structure, pricing and reimbursement, and marketed and pipelined products
  • Information on endovascular surgery techniques, procedural risks and follow-up treatment, and the clinical need for endovascular procedures
  • Company profiles of major players in the industry, including Boston Scientific Corp., Cardinal Health, Cook Group Inc., Getinge AB and Terumo Corp.

Key Topics Covered:

Chapter 1 Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Information Sources
  • Methodology and Information Sources
  • Regional Breakdown
  • Analyst's Credentials
  • Related Reports

Chapter 2 Summary and Highlights

Chapter 3 Aortic Aneurysm

  • Aortic Aneurysm
  • Causes and Risk Factors
  • Aging, Gender and Aortic Aneurysms
  • Global Demographics
  • U.S. Demographics
  • European Demographics
  • Japanese Demographics

Chapter 4 Abdominal Aortic Aneurysms

  • Disease Overview
  • Types of AAA
  • Infrarenal Aortic Aneurysms
  • Juxtarenal Aortic Aneurysms
  • Suprarenal Aortic Aneurysms
  • Slow-Growing AAAs
  • Fast-Growing AAAs
  • Risk Factors and Symptoms
  • Epidemiology and Economic Burden
  • Diagnosis
  • Treatment
  • Open Surgical Repair
  • Endovascular Aortic Repair (EVAR or EVAS)
  • Hybrid Approach
  • EVAR Versus Open Surgical Repair
  • Key Marketed and Pipeline Products
  • Key Marketed Products
  • Key Pipeline/R&D Products
  • Unmet Need
  • Current Challenges and Future Developments

Chapter 5 Thoracic Aortic Aneurysms

  • Disease Overview
  • Types of TAA by Shape
  • Types of TAA by Location/Segment
  • Thoracoabdominal Aortic Aneurysms
  • Risk Factors and Symptoms
  • Epidemiology and Economic Burden
  • Diagnosis
  • Treatment
  • Open Surgical Repair
  • Thoracic Endovascular Aortic Repair (TEVAR)
  • Hybrid Approach
  • TEVAR Versus Open Surgical Repair
  • Aortic Dissection
  • Disease Overview
  • Risk Factors and Symptoms
  • Epidemiology
  • Diagnosis and Treatment
  • Key Marketed and Pipeline Products
  • Key Marketed Products
  • Key Pipeline/R&D Products
  • Current Challenges and Future Developments

Chapter 6 Market Size and Growth Analysis

  • Market Size and Growth Analysis
  • Market Size and Growth Analysis by Region
  • Market Size and Growth Analysis by Segment
  • Market Size and Growth Analysis by Aneurysm Location
  • Market Size and Growth Analysis by Aneurysm Type
  • Market Growth Drivers and Restraints
  • Market Growth Drivers
  • Market Restraints

Chapter 7 Competitive Landscape in Endovascular Treatment Market

  • Competitive Landscape in Endovascular Treatment Market

Chapter 8 Market Strategies in the Endovascular Treatment Market

  • Recent Mergers and Acquisitions
  • Terumo Acquired Bolton Medical
  • Endologix and TriVascular Technologies Completed Merger
  • Cardinal Health Acquired Johnson & Johnson's Cordis Business
  • Lombard Medical Acquired Altura Medical
  • Medtronic Acquired Aptus Endosystems
  • Endologix Acquired Nellix
  • Boston Scientific Acquired TriVascular Technologies
  • LeMaitre Vascular Acquired Endomed
  • Endologix Merged with Radiance Medical
  • Johnson & Johnson (J&J) Through its Subsidiary Cordis Acquired TERAMed
  • Future Strategic Landscape

Chapter 9 Regulatory Structure: Medical Devices

  • Regulatory Background
  • Regulatory Systems for Medical Devices by Country/Region
  • U.S.
  • European Union (EU)
  • Japan

Chapter 10 Pricing and Reimbursement: Medical Devices

  • Pricing and Reimbursement Background
  • Pricing and Reimbursement for Medical Devices by Country/Region
  • U.S.
  • Europe
  • Japan

Chapter 11 Conclusions-Outlook for Endovascular Treatment Devices

  • Major Developments Influencing the Market
  • Technological Developments
  • Demographic and Economic Trends
  • Changing Structure of the Healthcare Industry
  • Long-Term Outlook for Endovascular Treatment

Chapter 12 Company Profiles

  • Altura Medical (Subsidiary Of Lombard Medical)
  • Biflow Medical
  • Blockade Medical Llc (Subsidiary Of Balt International)
  • Bolton Medical Inc. (Subsidiary Of Vascutek Terumo)
  • Boston Scientific Corp.
  • Braile Biomedica
  • Cardiatis Sa
  • Cardinal Health
  • Cook Group Inc.
  • Cordis Corp. (Subsidiary Of Cardinal Health Inc.)
  • Endologix
  • Endoluminal Sciences Pty Ltd.
  • Endomed (Subsidiary Of Lemaitre Vascular)
  • Endospan
  • Getinge Ab
  • Inspiremd
  • Japan Lifeline Co. Ltd.
  • Kawasumi Laboratories
  • Lemaitre Vascular Inc.
  • Lifetech Scientific
  • Lombard Medical Technologies
  • Medtronic
  • Microport Scientific
  • Microvention (Subsidiary Of Terumo)
  • Micrus Endovascular (Subsidiary Of Johnson & Johnson)
  • Nellix Inc. (Subsidiary Of Endologix)
  • Penumbra
  • Terumo Corp.
  • Transcatheter Technologies
  • Trivascular Technologies (Subsidiary Of Endologix Inc.)
  • W.L. Gore And Associates

Chapter 13 Appendix A: Acronyms

Chapter 14 Appendix B: Professional Organizations

  • American Heart Association
  • Center for Drug Evaluation and Research (CDER)
  • Center for Devices and Radiological Health (CDRH)
  • Centers for Medicare & Medicaid Services (CMS)
  • European Databank for Medical Devices (EUDAMED)
  • Food and Drug Administration (FDA or USFDA)
  • Hormone Foundation
  • International Diabetes Federation (IDF)
  • International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)
  • Network for Excellence in Health Innovation (NEHI)
  • National Center for Biotechnology Information (NCBI)
  • National Institute of Aging (NIA)
  • Pharmaceuticals and Medical Devices Agency (PMDA)
  • World Cancer Research Fund International
  • World Health Organization (WHO)

For more information about this report visit https://www.researchandmarkets.com/research/w5l6bk/global?w=5

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Cision View original content with multimedia:http://www.prnewswire.com/news-releases/global-endovascular-treatment-devices-2018-2022---major-players-profiled-include-boston-scientific-corp-cardinal-health-cook-group-inc-getinge-ab-and-terumo-corp-300700980.html

SOURCE Research and Markets

View Comments and Join the Discussion!